Table 2

Coronary intervention patient demographics

n=101
Age (year), mean±SD62.29±10.12
Male sex, n (%)84 (83.2)
Black, Asian, minority ethnic, n (%)58 (57.4)
Median BMI (IQR)27.55 (25.14–29.39)
Medical history, n (%)
 Hypertension55 (54.4)
 Hypercholesterolaemia62 (61.4)
 Diabetes mellitus31 (30.7)
 Smoking history20 (19.8)
 Previous MI31 (30.7)
 Previous PCI41 (40.6)
 Previous CABG9 (8.9)
LV ejection fraction (%), mean±SD53.70±7.27
Serum creatinine (μmol/L), mean±SD83.86±16.33
Elective procedure, n (%)72 (71.3)
Staged procedure following ACS, n (%)18 (17.8)
Angiogram±PCI for medically managed ACS11 (10.9)
Femoral access, n (%)15 (14.9)
Procedural type, n (%)
Diagnostic angiogram, n (%)33 (32.7)
 Medical management—no planned interventions12 (36.4)
 Workup for valve surgery1 (3)
 Investigations of troponin-positive events3 (9.1)
 Other surgery3 (9.1)
 Planned for staged PCI3 (9.1)
 Referral for CABG/MDT11 (33.3)
Diagnostic device used, no therapeutic intervention n (%)14 (13.9)
PCI, n (%)54 (54.5)
 left anterior descending artery31 (57.4)
 Left circumflex23 (42.6)
 Right coronary artery12 (22.2)
 Grafts2 (3.7)
 Diagnostic device used to guide PCI31 (57.4)
 Functional indices (FFR/iFR)5 (16.1)
 Intravascular ultrasound24 (77.4)
 Optical coherence tomography2 (6.4)
Procedural complexity
Multivessel PCI11 (20.4)
Number of stents used, mean±SD1.47±0.79
Length of segment treated (mm), mean±SD41.63±20.9
Bifurcation, n (%)8 (14.8)
Instent restenosis, n (%)4 (7.4)
CTO, n (%)4 (7.4)
Calcium modification, n (%)4 (7.4)
 Rotational atherectomy3 (5.6)
 Intravascular llthotripsy1 (1.9)
  • ACS, acute coronary syndrome; BMI, Body Mass Index; CABG, coronary artery bypass; LV, left ventricle; MDT, multidisciplinary team; MI, myocardial infarction; PCI, percutaneous coronary intervention.